SAMH
NBRV

Shanda Asset Management Holdings’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Shanda Asset Management Holdings’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-608
Closed -$103K – 114
2020
Q2 		$103K Buy
+608
New +$101K 0.01% 96

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return

Shanda Asset Management Holdings's NBRV Position: Q3 2020 in Review

Shanda Asset Management Holdings sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2020, closing a stake of 608 shares — an estimated $103K sold.

Shanda Asset Management Holdings first reported a position in NBRV in Q2 2020 and held it in 1 quarter. The position peaked at $103K in Q2 2020. 49 funds tracked by Wall St. Rank hold NBRV as of Q3 2020.

  • Shanda Asset Management Holdings reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2020 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 608 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2020, an estimated $103K.
  • Shanda Asset Management Holdings first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2020 and held it in 1 quarter.
  • Shanda Asset Management Holdings's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $103K in Q2 2020.
  • 49 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2020.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.